ABEC Expands Manufacturing Capability of Single-Use Disposable Containers for Biopharmaceutical Manufacturing
ABEC establishes ISO-7 cleanroom at its European Headquarters,
Fermoy, Co. Cork, Ireland, enhancing supply assurance for its global
Custom Single Run (CSR®) customers
BETHLEHEM, Pa.–(BUSINESS WIRE)–ABEC,
a leading global provider of integrated solutions and services for
biopharmaceutical manufacturing, today announced the completion of its
second ISO-7 cleanroom for single-use
disposable container (DC) manufacturing. ABEC’s Bethlehem, Pennsylvania,
USA, cleanroom has been fully operational since 2015, and the new
Fermoy, Ireland, cleanroom will be operational this April, adding
significant capacity while establishing supply redundancy for ABEC’s
global CSR
customers.
Complete, in-house DC manufacturing capability is a key element of
ABEC’s single-use strategy, enabling ABEC to deliver customized DC’s
globally that meet demanding quality and scheduling needs. Identical
tooling and operational procedures at the two facilities ensure
consistency of DC quality and performance. The CSR DC also utilizes
non-proprietary, commercially available materials, instruments, and
components, allowing customers to leverage existing qualification and
validation efforts. These factors combine to provide customers with
unprecedented control of single-use supply chains.
“A flexible and reliable supply of high quality DC’s is critical to
our customers’ single-use manufacturing operations,” said Scott
Pickering, ABEC President and CEO. “ABEC’s new state-of-the art
cleanroom in Fermoy greatly enhances our DC supply capability and
further reduces our customers’ single-use supply chain risk.”
Partners for ABEC’s cleanroom are: ClearSphere
and Kingspan.
Visit Cleanroom
Technology Magazine for ClearSphere’s article Turnkey
Solution for a Bespoke Cleanroom, published February, 2018, page
22 -25.
About ABEC
Since 1974, ABEC has been a global leader in delivering integrated
process solutions and services for manufacturing in the
biopharmaceutical industry. A majority of the world's pharmaceutical and
biotech companies are ABEC customers; with many of today's leading
therapies manufactured by processes and equipment engineered,
manufactured, installed and serviced by ABEC. ABEC's unique value is
based on long experience, complete in-house capabilities, a custom,
flexible approach and long-term credibility. ABEC's turn-key solutions
and support services reduce overall cost and time to market while
delivering maximum productivity. Visit www.abec.com,
www.abecsingleuse.com,
email [email protected], follow ABEC on LinkedIn.
Contacts
ABEC
Media Inquiries:
Susan Cooper Curcio, +1 610-861 4666
[email protected]